Stratification
From TrialTree Wiki
Stratification
Stratification is a technique used during randomization to ensure that important prognostic factors or baseline characteristics are evenly distributed across treatment groups. This improves balance, reduces confounding, and enhances statistical power.
Why Use Stratification in RCTs?
- Ensures Balance of Key Variables
- Prevents imbalance in critical characteristics such as age, sex, and disease severity.
- Particularly important in small trials, where chance imbalances have greater impact.
- Improves Statistical Efficiency
- Reduces outcome variability and increases the precision of treatment effect estimates.
- Minimizes the need for post-hoc statistical adjustments.
- Minimizes Confounding
- Balances known risk factors across groups to strengthen internal validity.
- Example: Stratifying by smoking status in a lung cancer trial.
How Stratification Works
- Identify Key Stratification Factors
- Select 2–4 factors that are strongly associated with the outcome (e.g., age, disease stage, biomarker status).
- Avoid over-stratification to prevent logistical challenges.
- Create Strata (Subgroups)
- Categorize participants into distinct groups prior to randomization.
Example: In a diabetes RCT:
- Stratum 1: Male, Age < 50
- Stratum 2: Male, Age ≥ 50
- Stratum 3: Female, Age < 50
- Stratum 4: Female, Age ≥ 50
- Randomize Within Each Stratum
- Use separate randomization sequences for each stratum.
- Often implemented using block randomization to ensure equal group sizes within each stratum.
When to Use Stratification
- Small to Medium-Sized Trials
- More vulnerable to imbalance by chance.
- Heterogeneous Populations
- When participant characteristics (e.g., disease severity) vary widely.
- When Known Prognostic Factors Affect Outcomes
- E.g., in stroke trials, stratify by age and stroke severity to maintain group comparability.
Examples of Stratification in RCTs
- Cardiology Trial: Stratified by hypertension status to balance blood pressure-related risk.
- Cancer Trial: Stratified by tumor stage to ensure even distribution across treatment arms.
- COVID-19 Trial: Stratified by vaccination status to account for prior immunity.
Challenges and Limitations
| Challenge | Explanation |
|---|---|
| Too Many Stratification Factors | Over-stratification leads to small subgroup sizes, reducing randomization efficiency. |
| Requires Pre-Specified Factors | Stratification must be defined before randomization and cannot be changed post hoc. |
| May Require Specialized Software | Tools like REDCap, R, or SAS are often needed to implement stratified randomization. |
Alternatives to Stratification
- Minimization
- A dynamic method that adjusts assignment in real time to reduce imbalance across multiple variables.
- Covariate Adjustment in Analysis
- If stratification is not feasible, adjust for important prognostic variables in the statistical model.
Conclusion
Stratification is a valuable method to enhance fairness, precision, and scientific validity in RCTs. When implemented thoughtfully, it helps ensure balanced treatment groups and more credible results.
Bibliography
- Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI. Stratified randomization for clinical trials. Journal of Clinical Epidemiology. 1999;52(1):19–26.
- Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. The Lancet. 2002;359(9306):614–618. Discusses stratification as a method to ensure allocation balance.
- ICH E9. Statistical Principles for Clinical Trials. International Council for Harmonisation; 1998. Section 5.3 covers stratification in randomization.
- Altman DG, Bland JM. Treatment allocation by minimisation. BMJ. 2005;330(7495):843. Compares stratification with minimization approaches.
- Piantadosi S. Clinical Trials: A Methodologic Perspective. 3rd ed. Wiley; 2017. Chapter on randomization and stratification methods in trial design.
Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.